Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intelligent Digital Tools for Screening of Brain Connectivity and Dementia Risk Estimation in People Affected by Mild Cognitive Impairment
Sponsor: Oslo University Hospital
Summary
Every three seconds someone in the world develops dementia. There are over 50 million people worldwide living with dementia and by 2030 this figure is expected to reach 82 million. Besides time-consuming patient investigations with low discriminative power for dementia risk, current treatment options focus on late symptom management. By screening brain connectivity and dementia risk estimation in people affected by mild cognitive impairment, the European Union (EU) funded AI-Mind project will open the door to extending the 'dementia-free' period by offering proper diagnosis and early intervention. AI-Mind will develop two artificial intelligence-based digital tools that will identify dysfunctional brain networks and assess dementia risk. Personalised patient reports will be generated, potentially opening new windows for intervention possibilities.
Key Details
Gender
All
Age Range
60 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2021-03-01
Completion Date
2026-02-27
Last Updated
2024-04-02
Healthy Volunteers
No
Locations (5)
Helsinki University Hospital
Helsinki, Finland
Università Cattolica del Sacro Cuore Campus di Roma
Roma, Italy
Scientific Institute for Research, Hospitalization and Healthcare
Roma, Italy
Oslo University Hospital
Oslo, Norway
Universidad Complutense de Madrid
Madrid, Spain